Globalization and Democratization of Innovation

Odyssey buys BenevolentAI in Europe's top SPAC deal

The End of Silicon Valley as We Know It?

Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design

Investment Into Biosciences Boomed, Could The Bubble Burst?

Top 10 Emerging Technologies of 2021

Exscientia : Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters' Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement

Innovation at the intersection of design and technology

European Biotech Investors Cap Off Record Year in Fundraising

Google’s DeepMind turns first profit as revenues soar